Martingale Asset Management’s CureVac CVAC Stock Holding History

Martingale Asset Management’s Portfolio CVAC Stock Details CVAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-48,812	Closed	-$665K	–	836
2022 Q2	$665K	Buy	48,812 +7,770	+19%	+$129K	0.01%	581
2022 Q1	$805K	Buy	+41,042	New	+$819K	0.01%	537

Other funds holding CVAC

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Martingale Asset Management's CVAC Position: Q3 2022 in Review

Martingale Asset Management sold out of CureVac (CVAC) in Q3 2022, closing a stake of 48,812 shares — an estimated $665K sold.

Martingale Asset Management first reported a position in CVAC in Q1 2022 and held it in 2 quarters. The position peaked at $805K in Q1 2022. 83 funds tracked by Wall St. Rank hold CVAC as of Q3 2022.

Martingale Asset Management reported no remaining CureVac position as of Q3 2022 after selling out during the quarter.
Martingale Asset Management sold 48,812 CureVac shares in Q3 2022, an estimated $665K.
Martingale Asset Management first reported a position in CureVac in Q1 2022 and held it in 2 quarters.
Martingale Asset Management's CureVac position peaked at $805K in Q1 2022.
83 funds tracked by Wall St. Rank held CureVac as of Q3 2022.

Based on Martingale Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.